Department of Radiation Oncology,Hangzhou Cancer Hospital,Hangzhou 310002 China (Zhao RP);Department of Radiation Oncology,Cancer Hospital of Fudan University,Department of Oncology,Shanghai Medical College of Fudan University,Shanghai 200032,China (Yu XL,Zhang Z,Feng Y,Yang ZZ,Wang J,Guo XM)
Abstract：Objective To investigate the treatment outcome of patients with localized soft tissue sarcoma (STS) and related prognostic factors, with a focus of the role of postoperative radiotherapy in the treatment of STS. Methods A retrospective analysis was performed for the clinical data of 203 STS patients who underwent organ preservation surgery in Fudan University Shanghai Cancer Center from July 2000 to July 2010. Of all the patients, 76(37.4%) received adjuvant radiotherapy, which was delivered via anterior-posterior parallel opposed fields at a dose of 45-70 Gy. The Kaplan-Meier method was used to calculate survival rates, the log-rank test was used for survival difference analysis, and the Cox proportional hazards model was used for multivariate analysis. Results The follow-up rate was 100%. The 5-year overall survival (OS) rate, local failure-free survival rate, and distant metastasis-free survival rate were 69.1%, 69.2%, and 68.0%, respectively. The multivariate analysis showed that pathological subtype, tumor size, resection margin status, and postoperative radiotherapy were influencing factors for OS. Among these factors, postoperative radiotherapy was associated with a significantly reduced risk of local recurrence in STS patients (HR=0.327, 95%CI 0.177-0.605, P=0.000) and a significantly increased OS rate (HR=0.489, 95%CI 0.266-0.897, P=0.021). Conclusions Postoperative radiotherapy can reduce local recurrence and improve OS in patients with localized STS, and further studies are needed to clarify its role.
Zhao Ruping,Yu Xiaoli,Zhang Zhen et al. Effect of postoperative adjuvant radiotherapy on treatment outcome of patients with localized soft tissue sarcoma[J]. Chinese Journal of Radiation Oncology, 2016, 25(9): 934-938.
[1] Pisters PW,Harrison LB,Leung DH,et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma[J].J Clin Oncol,1996,14(3):859-868. [2] Yang JC,Chang AE,Baker AR,et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity[J].J Clin Oncol,1998,16(1):197-203. [3] Krasin MJ,Davidoff AM,Xiong XP,et al. Preliminary results from a prospective study using limited margin radiotherapy in pediatric and young adult patients with high-grade nonrhabdomyosarcoma soft-tissue sarcoma[J].Int J Radiat Oncol Biol Phys,2010,76(3):874-878.DOI:10.1016/j.ijrobp.2009.02.074. [4] Jebsen NL,Trovik CS,Bauer HCF,et al. Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma:a Scandinavian sarcoma group study[J].Int J Radiat Oncol Biol Phys,2008,71(4):1196-1203.DOI:10.1016/j.ijrobp.2007.11.023. [5] Alektiar KM,Velasco J,Zelefsky MJ,et al. Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity[J].Int J Radiat Oncol Biol Phys,2000,48(4):1051-1058.DOI:10.1016/S0360-3016(00)00753-7. [6] Koshy M,Rich SE,Mohiuddin MM.Improved survival with radiation therapy in high-grade soft tissue sarcomas of the extremities:a SEER analysis[J].Int J Radiat Oncol Biol Phys,2010,77(1):203-209.DOI:10.1016/j.ijrobp.2009.04.051. [7] Alkis N,MuallaoluS,KoBer M,et al. Primary adult soft tissue sarcomas:analysis of 294 patients[J].Med Oncol,2011,28(1):391-396.DOI:10.1007/s12032-010-9450-2. [8] Voigt JJ.Recommendations of the FNCLCC Sarcoma Group for pathologic management of soft tissue sarcoma in adults[J].Ann Pathol,1999,19(2):153. [9] Guillou L,Coindre JM,Bonichon F,et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma[J].J Clin Oncol,1997,15(1):350-362. [10] Pisters PW,Leung DH,Woodruff J,et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities[J].J Clin Oncol,1996,14(5):1679-1689. [11] Gutierrez JC,Perez EA,Franceschi D,et al. Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry[J].J Surg Res,2007,141(1):105-114.DOI:10.1016/j.jss.2007.02.026. [12] Gronchi A,Lo VS,Colombo C,et al. Extremity soft tissue sarcoma in a series of patients treated at a single institution:local control directly impacts survival[J].Ann Surg,2010,251(3):506-511.DOI:10.1097/SLA.0b013e3181cf87fa. [13] Lewis JJ,Leung D,Heslin M,et al. Association of local recurrence with subsequent survival in extremity soft tissue sarcoma[J].J Clin Oncol,1997,15(2):646-652. [14] Gerrand CH,Bell RS,Wunder JS,et al. The influence of anatomic location on outcome in patients with soft tissue sarcoma of the extremity[J].Cancer,2003,97(2):485-492. DOI:10.1002/cncr.11076. [15] Linehan DC,Lewis JJ,Leung D,et al. Influence of biologic factors and anatomic site in completely resected liposarcoma[J].J Clin Oncol,2000,18(8):1637-1643. [16] Stojadinovic A,Leung DHY,Allen P,et al. Primary adult soft tissue sarcoma:time-dependent influence of prognostic variables[J].J Clin Oncol,2002,20(21):4344-4352.DOI:10.1200/JCO.2002.07.154. [17] Cakir S,Dincbas FO,Uzel O,et al. Multivariate analysis of prognostic factors in 75 patients with soft tissue sarcoma[J].Radiother Oncol,1995,37(1):10-16.DOI:10.1016/0167-8140(95)01614-M. [18] Zagars GK,Ballo MT,Pisters PW,et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy:an analysis of 1225 patients[J].Cancer,2003,97(10):2530-2543.DOI:10.1002/cncr.11365.
2016, Vol. 25 
